Skip to main content
. 2021 Aug 24;8:20499361211036773. doi: 10.1177/20499361211036773

Figure 1.

Figure 1.

Current research priorities to improve infectious complications of CAR T-cell therapy.

CAR, chimeric antigen receptor; CMV, cytomegalovirus; CRS, cytokine release syndrome; ICANS, immune effector cell neurotoxicity syndrome; IVIG, intravenous immune globulin.